News Sentiment

GUFICBIO sentiment intelligence

Gufic Biosciences Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 17 relevant articles
Exchange NSI India
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 392.40 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 17

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+0.6% over one week, +5.7% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

Gufic Biosciences Q4 Net Profit Jumps 157% to ₹20.6 Cr as Revenue Hits ₹252 Cr

Market Reaction

Balanced read

51/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 0.6% Price digesting
Trend fit Trend active 5.7% over four weeks
Fair value 14.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 16
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 17
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
scanx.trade 5
Sahi 1
marketscreener.com 1
Business Standard 1
Upstox 1
The Times of India 1
The Economic Times 1
ET HealthWorld 1

Event Lens

What the news is about

Classified themes
Market update 12
Earnings 3
Guidance 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-17 of 17